Latus Bio logo

Latus Bio Funding & Investors

Philadelphia, PA

Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.

latusbio.com

Total Amount Raised: $54,000,000

Latus Bio Funding Rounds

  • Series A

    $54,000,000

    Series A Investors

    EIGHT PARTNERS VC
    DCVC Bio
    Samsung Life Science Fund
    Gaingels
    Modi Ventures
    Children's Hospital of Philadelphia
    Ben Franklin Technology Partners
Funding info provided by Diffbot.